Maze Therapeutics Inc (MAZE)

SG&A Expense Growth

5.56%

Quarterly · Period ending:

MAZE logo

MAZE SG&A Expense Growth

Latest reported5.56%
MAZE Quarterly SG&A Growth (QoQ) (0.00% → 5.56%)
High-resolution chart · PNG

MAZE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maze Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
5.5623%
18.2668%
34.9068%
-7.0643%
6.9684%
4.1411%
9.2841%
16.4943%
-3.8781%
-12.4037%
21.4211%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.